ANDA 212602, held by Invagen Pharms. Colesevelam Hydrochloride.
As of Nov 15, 2026, ANDA 212602 (Colesevelam Hydrochloride), held by Invagen Pharms, was first approved by FDA on Apr 20, 2020, with 0 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Apr 20, 2020 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Colesevelam Hydrochloride625MG ยท tablet;oral | Colesevelam Hydrochloride | Discontinued |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters